|
|
|
¶ó½ºÇǸ°Ä¸½¶100/5mg Raspirin Cap. 100/5mg
|
Àü¹®ÀǾàÇ° | ±Þ¿©
|
|
|
|
|
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàÇ° ÀÎÅÍ³Ý ÆǸŸ¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
Èò»öÀÇ Àå¿ëÆç·¿°ú ³ë¶õ»öÀÇ ¿øÇü Àå¿ëÄÚÆÃÁ¤ÀÌ µç »óºÎ ¿¬ÇÑ ºÐÈ«»ö, ÇϺΠÈò»öÀÇ °æÁúĸ½¶Á¦
|
|
|
|
|
|
Á¦Á¶È¸»ç |
Çѹ̾àÇ°(ÁÖ)
|
ÆǸÅȸ»ç |
Çѹ̾àÇ°(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2023.10.30)
|
BIT ¾àÈ¿ºÐ·ù |
Ç×Ç÷Àü,Ç÷¼ÒÆÇÀÀÁý¾ïÁ¦Á¦ (Antithrombotics, Antiplatelet Agents)
|
º¹ÁöºÎºÐ·ù |
219[±âŸÀÇ ¼øȯ°è¿ë¾à ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
643508750 \399 ¿ø/1ĸ½¶(2024.07.01)(ÇöÀç¾à°¡)\399 ¿ø/1ĸ½¶(2024.02.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
Acetylsalicylic acid, combinations with proton pump inhibitors / B01AC56 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
|
÷°¡Á¦ |
¸ð³ë¾Øµð±Û¸®¼¼¸®µå,
»êȸ¶±×³×½·,
»êÈƼź,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
¿¡Æ¿¼¿·ê·Î¿À½º,
ÀúġȯµµÈ÷µå·Ï½ÃÇÁ·ÎÇʼ¿·ê·Î¿À½º,
Ä«¸£³ª¿ì¹Ù³³,
Ä«¸£º¹½Ã¸ÞÆ¿¼¿·ê·Î¿À½ºÄ®½·,
ĸ½¶,
ÅÅÅ©,
Ȳ»ö»êÈö,
È÷µå·Ï½ÃÇÁ·ÎÇʼ¿·ê·Î¿À½º,
È÷ÇÁ·Î¸á·Î¿À½ºÇÁÅ»·¹ÀÌÆ®,
D-¸¸´ÏÅç
|
|
|
|
|
|
|
|
|
|
Ç× ¸ñ |
³» ¿ë |
|
|
|
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-06-28 |
|
|
|
|
|
|
|
|